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Abstract
Purpose. Adverse drug reactions (ADR) including medication allergies are not welldescribed among large national cohorts. This study described the most common
documented medication allergies and their reactions among a national cohort of
Veterans Affairs (VA) inpatients.
Methods. We evaluated inpatient admissions in any VA Medical Center from 1/1/2000
to 12/31/2014. Each admission was linked with allergy history preceding or upon
admission. Individual drugs were aggregated into drug class category including:
penicillins, sulfonamides, angiotensin converting enzyme (ACE) inhibitors, opiates,
HMG-CoA reductase inhibitors (“statins”) and non-steroidal anti-inflammatory inhibitors
(NSAID). Results were reported in aggregate and over time.
Results. Approximately ~10.8 million inpatient admissions occurred from 2000 – 2014.
We found the most commonly reported allergy drug classes were penicillins (13%,
n=1,410,080), opiates (9.1%, n=984,978), ACE inhibitors (5.7%, n=618,075)
sulfonamides (5.1%, n=558,653), NSAIDs (5.1%, n=551,216) and statins (3.6%,
n=391,983). Several allergy histories increased over time including opiates (6.2 to
11.2%), ACE inhibitors (1.3 to 10.2%), statins (0.3 to 7.3%) and NSAIDs (3.9 to 6.0%).
Rash was the most commonly documented reaction on reports for penicillins (25.5%,
n=371,825), sulfonamides (25.6%, n=165,954), and NSAIDs (10.3%, n=65,741). The
most common reaction for opiates was nausea/vomiting (17.9%, n=211,864),
cough/coughing for ACE inhibitors (41.0%, n=270,537) and muscle pain/myalgia for
statins (34.1%, n=186,565).
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Conclusions. We report that penicillins and opiates are the most commonly
documented drug allergies among VA inpatients, but other drug classes such as ACE
inhibitors, statins and NSAIDs are becoming increasingly common. Clinicians also
commonly document non-allergic ADRs in the allergy section such as cough or myalgia.
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Introduction
Adverse drug reactions (ADR) including medication allergies are a common and
burdensome reality in patients’ treatment. However ADRs are difficult to study in large
databases because they are often not identified in health claims or other reports.1, 2
Allergy databases may represent an important potential data source for studying ADRs.
Thus, we undertook a study to describe the most common documented medication
allergies and their reactions among inpatients receiving care in the Veterans Affairs
(VA) health care system. We focused on the VA health care system for two reasons.
First, the VA is the nation’s largest integrated health care delivery system, caring for
approximately 9 million Veterans and operating 144 medical centers and 1200
outpatient clinics throughout the US.3 Second, the VA’s comprehensive electronic
health record includes detailed information on documented “allergies” to specific
medications.
Methods
We evaluated inpatient admissions in any VA Medical Center from 1/1/2000 to
12/31/2014. Admissions included acute care as well as short-stay observations,
domiciliary stays, or long-term nursing care stays during the study period. Each unique
admission was linked with allergy history preceding or upon admission. Allergy histories
correspond to the general allergy section of the electronic medical record and could be
documented from a variety of previous health encounters (e.g. previous admission,
outpatient clinic or pharmacy visit). Individuals without any allergy records were
assumed to have no known drug allergies. For comparison to previous studies, we
identified individual drugs and combined them into their respective drug class

5
category.4,5 Natural and other synthesized penicillins were combined into one “penicillinclass” category (e.g. penicillin, ampicillin, amoxicillin, methicillin, dicloxacillin, oxacillin,
nafcillin, piperacillin, carbenicillin and ticarcillin). Sulfonamides included documented
“sulfa” allergies not otherwise specified or specific sulfonamide antibiotic (trimethoprim,
sulfacetamide, sulfadiazine, sulfamethoxazole, sulfasalazine and dapsone). Angiotensin
converting enzyme (ACE) inhibitors included lisinopril, enalapril, ramipril, quinapril,
perindopril, benazepril, fosinopril and captopril. Opiates included codeine, morphine,
fentanyl, hydromorphone, oxycodone, methadone and meperidine. HMG-CoA
reductase inhibitors (“statins”) included simvastatin, atorvastatin, rosuvastatin,
pravastatin, fluvastatin and lovastatin. Non-steroidal anti-inflammatory inhibitors
(NSAID) included aspirin, ibuprofen, naproxen, indomethacin, ketorolac, diclofenac,
sulindac, etodolac, piroxicam and meloxicam. This study was approved by the
Providence VA Institutional Review Board and Research and Development Committee.
Results
Overall we identified 2,948,543 patients with 10,858,398 admissions from 2000 –
2014. These admissions were included from 127 VA Medical Centers across 48 states,
Washington D.C. and Puerto Rico. Among admissions, 95.2% (n=10,339,233) were
male, with a mean age of 63 (± 14 years). We found the most common allergies were
penicillins (13%, n=1,410,080), opiates (9.1%, n=984,978), ACE inhibitors (5.7%,
n=618,075) sulfonamides (5.1%, n=558,653), NSAIDs (5.1%, n=551,216) and statins
(3.6%, n=391,983). The most common individual drugs included penicillin, codeine,
lisinopril, simvastatin, morphine, aspirin and trimethoprim/sulfamethoxazole (Table 1).
Penicillins and sulfonamides allergies increased ≤1% during the study period (Figure 1).
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The other allergy histories that increased over time included opiates (6.2 to 11.2%),
ACE inhibitors (1.3 to 10.2%), statins (0.3 to 7.3%) and NSAIDs (3.9 to 6.0%).
Missing documentation about reactions was common ranging from 22.5 to 43.3% of
reports by drug class (Table 1). Rash was the most commonly documented reaction on
reports for penicillins (25.5%, n=371,825), sulfonamides (25.6%, n=165,954), and
NSAIDs (10.3%, n=65,741). The most common reaction for opiates was
nausea/vomiting (17.9%, n=211,864). Cough/coughing was the most common reaction
for ACE inhibitor allergy reports (41.0%, n=270,537). Statin allergies most commonly
stated a muscle pain/myalgia reaction on reports (34.1%, n=186,565).
Discussion
We report that penicillins and opiates are the most commonly documented drug
allergies among inpatients in the VA system, but other drug classes such as ACE
inhibitors, statins and NSAIDs are becoming increasingly common. Previous studies
have found similar rates of penicillin allergies, and it is commonly reported that 10-15%
of admitted patients are allergic to penicillins.6-9 A similarly designed study of health
care plan members in the Southern California Kaiser Permanente system, which
included both inpatients and outpatients found overall lower allergy prevalence rates
(penicillin [7.9%], sulfonamide [4.3%], narcotic [3.7%], NSAIDs [2.1%], ACE inhibitors
[1.3%]) than our study.5 However, they also found ACE inhibitors, NSAIDs and narcotics
to be among the most commonly reported allergies. Only one other published study has
investigated documented allergy trends over time.4 This single-center study which
evaluated allergy prevalence from 1990-2013 reported similar prevalence findings for
penicillins (12.8%), ACE inhibitors (2.0%), sulfonamides (7.4%), opiates (6.8%), and
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NSAIDs (3.5%), as well as demonstrating a similar increase in ACE inhibitor, opiate,
and statin allergies over time. Few studies have described the type of reactions reported
by patients/providers. In a single-center study with retrospective chart review and
patient interview which evaluated documented antimicrobial allergies and patient
reported reactions, type I-IV hypersensitivity for penicillins and sulfonamides were
classified for 69/198 [35%] and 28/88 [32%] of allergies respectively. 12 A large national
evaluation of outpatient medical records demonstrated that the presence of an “allergiclike event” (a combined definition of anaphylaxis, urticaria, angioedema and severe skin
reactions) to penicillin does increase the likely occurrence of another reaction to
cephalosporin or sulfonamide, but serious allergic hypersensitivities are relatively rare
overall (<0.001%).13
In our study, the large number of ACE inhibitor and statin “allergies” and their
increase over time was unanticipated. ACE inhibitor and statin allergic hypersensitivities
have not previously been described with comparable frequency to opiates and
sulfonamide drugs.10 Documentation is subject to the historian judgment and patient
recall, therefore the term “allergy” could also refer to other serious non-allergic ADRs
which were deemed appropriate to document at the time. This is supported by our
findings on the most commonly described reactions with each drug (Table 1).
Clinicians may document non-allergic ADRs in the allergy domain to inform other
providers to avoid these medications, such as ACE inhibitor-induced cough or muscle
pain from statin therapy. These commonly reported ADRs (e.g. ACE inhibitor cough)
raise the possibility that the “allergy” histories of VA patients (and possibly other
electronic medical record systems) may contain substantial information on a variety of
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historical adverse drug reactions not just allergic reactions. Review of allergy domains in
electronic medical record systems may prove to be an untapped source for
pharmacovigilance and post-marketing surveillance of medications. Future electronic
health record (EHR) innovations could explicitly divide these sections into “allergy”,
“intolerance”, and “food” to reduce this technical inaccuracy. A system which allows for
greater specificity in documenting drug and food reactions could improve patient safety
as clinicians will be able to make better informed decisions for patient management in
the presence of such reaction histories. A significant limitation to this approach may be
the accuracy of the documented allergy. Inaccuracy in documentation can be two-fold,
1) the history could be inaccurately recorded or 2) the history even when accurately
taken from the patient may not actually be related to any real hypersensitivity. Patients
with documented penicillin allergies often do not have physiologic reactions, but among
other documented “allergies” the overall likelihood of actual ADRs after rechallenge is
not well-described.14 One study compared documented allergy records vs. actual
patient interview in an emergency department setting and found significant
discordance.15
In our study, the reactions reported generally reflect the ADR profile of that agent
(i.e. cough, angioedema, hyperkalemia for ACE inhibitors; Table 1) and even if the
allergy documentation is inaccurate, these “allergies” could still be useful as they
influence treatment decisions regardless of the accuracy.8 Therefore, we highlight the
opportunity to investigate documented “allergies” with regards to general ADR trends
and how they impact drug utilization and health outcomes.
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Document Allergies Over Time, 2000-2014
Penicillins
Opiates
ACE inhibitors
Sulfonamides
NSAID
Statins
Admissions
with any
1,410,080 (13.0)
984,978 (9.1)
618,075 (5.7)
558,653 (5.1)
551,216 (5.1)
391,983 (3.6)
allergy
Penicillin
Codeine
Lisinopril
NOS
Aspirin
Simvastatin
1,289,229 (91.4)
526,825 (53.5) 474,567 (76.8)
414,214 (74.1)
251,907 (45.7)
307,316 (78.4)
Amoxicillin
Morphine
NOS
TMP/SMX
Ibuprofen
Atorvastatin
96,348
(6.8)
268,332
(27.2)
62,380
(10.1)
188,792
(33.8)
171,730
(31.2)
64,025
(16.3)
By druga
Ampicillin
Oxycodone
Fosinopril
Sulfacetamide
Naproxen
Pravastatin
(% of
37,211 (2.6)
121,870 (12.4) 61,778 (10.0)
17,165 (3.1)
69,599 (12.6)
48,659 (12.4)
class)
Piperacillin
Meperidine
Enalapril
Sulfasalazine
Ketorolac
Rosuvastatin
17,939 (1.3)
95,179 (9.7)
19,694 (3.2)
7,924 (1.4)
34,169 (6.2)
37,865 (9.7)
Dicloxacillin
Hydrocodone
Benazepril
Sulfadiazine
Indomethacin
Fluvastatin
7,275 (0.5)
92,661 (9.4)
16,575 (2.7)
4,956 (0.9)
26,815 (4.9)
29,045 (7.4)
Total
1,458,269
1,181,299
660,563
647,948
638,643
547,168
allergiesb
Nausea/
Cough/
Muscle pain/
Rash
Rash
Rash
vomiting
coughing
myalgia
371,825 (25.5)
165,954 (25.6)
65,741 (10.3)
211,864 (17.9) 270,537 (41.0)
186,565 (34.1)
Hives/urticaria
Rash
“Other”
Hives/urticaria
Nausea/vomiting
“Other”
By
201,828 (13.8)
130,176 (11.0)
43,946 (6.7)
67,806 (10.5)
64,208 (10.1)
50,609 (9.2)
reactionc
“Other”
Hives/urticaria
Angioedema
“Other”
“Other”
Weakness
(% of
62,036 (4.3)
75,202 (6.4)
42,312 (6.4)
33,515 (5.2)
60,919 (9.5)
22,316 (4.1)
allergies)
Swelling/ edema
“Other”,
Hyperkalemia Nausea/vomiting
Hives/urticaria
Rash
85,687 (5.9)
58,143 (4.9)
28,968 (4.4)
32,652 (5.0)
41,897 (6.6)
18,742 (3.4)
Anaphylaxis
Pruritis
Rash
Anaphylaxis
GI reaction
Diarrhea
45,573 (3.1)
12,695 (1.1)
21,445 (3.2)
8,310 (1.3)
15,471 (2.4)
11,666 (2.1)
Missing
632,073 (43.3)
415,459 (35.2) 148,629 (22.5)
273,798 (42.3)
247,827 (38.8)
133,793 (24.5)
reaction
Description. Total admissions (n=10,858,398). The most common allergy classes, individual drugs and the most common
reactions reported. ACE – angiotensin converting enzyme, NSAID – non-steroidal anti-inflammatory drugs, N/V –
Nausea/Vomiting, GI - gastrointestinal. NOS – Not otherwise specified. TMP/SMX – Trimethoprim/Sulfamethoxazole.
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An individual admission could have multiple allergies in the same class listed so these values exceed the “any allergy”
count (e.g. patient had both penicillin and amoxicillin listed).
b- “Total allergies” refers to unique individual allergy records per admission (vs. any allergy).
c- Each allergy could have more than one recorded reaction so reaction counts exceed total allergies. Allergy histories
stated “other reaction” for many entries.
a-
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Figure 1. Veteran Health Administration documented “allergies” among inpatient
admissions from 2000 - 2014. ACEi – angiotensin converting enzyme inhibitors,
NSAIDs – non-steroidal anti-inflammatory drugs.

